Search results
Professor of Pediatrics. The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer. Our goal is to develop an arsenal of new compounds-a “chemical toolbox”-to investigate and block protein interactions that cause cancer.
MD, PhD. Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Director, Harvard/MIT MD-PhD Program. Professor of Pediatrics, Harvard Medical School. Request an Appointment. Phone: 888-733-4662. Fax: 617-582-8240. NPI: 1508896853. Print Profile. Locations. Boston.
The Walensky laboratory specializes in the chemical biology of deregulated apoptotic, transcriptional, and metabolic pathways in cancer, emphasizing the chemical, structural, and cell biology of the BCL-2 family signaling network.
487. 2010. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. GL Verdine, LD Walensky. Clinical cancer research 13 (24), 7264-7270. , 2007. 474. 2007. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Professor of Pediatrics. The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer. Our goal is to develop an arsenal of new compounds-a “chemical toolbox”-to investigate and block protein interactions that cause cancer.
Email: loren_walensky@dfci.harvard.edu. Website: http://www.hms.harvard.edu/dms/bbs/fac/walensky.php Lab Size: 15-20. Summary. The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer.
May 1, 2019 · Loren David Walensky, M.D., Ph.D. Professor of Pediatrics. 617-355-6369. Email. Publications View. Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice. Authors: Authors: Mourtada R, Herce HD, Yin DJ, Moroco JA, Wales TE, Engen JR, Walensky LD. Nat Biotechnol 2019-10-01.
